HCA Healthcare, Inc. (HCA)

Stock Price Forecast

The 16 analysts that cover HCA Healthcare stock have a consensus rating of "Buy" and an average price target of $392.93, which forecasts a 5.01% increase in the stock price over the next year. The lowest target is $336 and the highest is $440.

Price Target: $392.93 (+5.01%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$336	$392.93	$400	$440
Change	-10.21%	+5.01%	+6.90%	+17.59%

Analyst Ratings

The average analyst rating for HCA Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	4	4	4	4
Buy	7	7	7	6	6	6
Hold	4	4	4	6	7	6
Sell	1	1	1	1	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	16	17	17	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $376 → $404	Buy	Maintains	$376 → $404	+7.97%	Jun 23, 2025
Craig Hettenbach Morgan Stanley	Morgan Stanley	Hold Maintains $355 → $410	Hold	Maintains	$355 → $410	+9.57%	Jun 9, 2025
Andrew Mok Barclays	Barclays	Buy Maintains $366 → $416	Buy	Maintains	$366 → $416	+11.17%	Jun 2, 2025
Stephen Baxter Wells Fargo	Wells Fargo	Sell → Hold Upgrades $320 → $385	Sell → Hold	Upgrades	$320 → $385	+2.89%	May 29, 2025
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $384 → $376	Buy	Maintains	$384 → $376	+0.48%	Apr 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

75.46B

Increased by 6.88%

from 70.60B

Revenue Next Year

79.37B

Increased by 5.18%

from 75.46B

EPS This Year

25.60

Increased by 16.34%

from 22.00

EPS Next Year

28.42

Increased by 11.02%

from 25.60

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	51.53B	58.75B	60.23B	64.97B	70.60B	75.46B	79.37B	83.53B
Revenue Growth	0.38%	14.01%	2.52%	7.86%	8.67%	6.88%	5.18%	5.25%
EPS	10.93	21.16	19.15	18.97	22.00	25.60	28.42	32.16
EPS Growth	8.54%	93.60%	-9.50%	-0.94%	15.97%	16.34%	11.02%	13.19%
Forward PE	-	-	-	-	-	14.62	13.17	11.63
No. Analysts	-	-	-	-	-	27	26	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	79.6B	84.9B	90.4B
Avg	75.5B	79.4B	83.5B
Low	72.2B	75.7B	79.3B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	12.7%	12.5%	13.9%
Avg	6.9%	5.2%	5.3%
Low	2.2%	0.3%	-0.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	27.17	31.49	35.77
Avg	25.60	28.42	32.16
Low	24.16	26.50	30.44

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	23.5%	23.0%	25.9%
Avg	16.3%	11.0%	13.2%
Low	9.8%	3.5%	7.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.